Topic
9 articles covering Haematology in medical tourism and healthcare in India.
Subscribe via RSS
India now performs 2,000+ BMTs annually. Affordable haematological transplants for global patients — the complete 2026 guide to bone marrow transplant process, costs, and outcomes.
Gene therapy for sickle cell disease is receiving global attention. India is expanding access to curative treatments for African patients — the complete 2026 update.
Lymphoma treatment in India — RCHOP, ICE, ABVD protocols, CAR-T eligibility, PET-CT monitoring, and costs vs USA for African international patients.
Multiple myeloma treatment in India — VRd/DaraVRd induction, autologous stem cell transplant costs USD 25,000–35,000, new drug options for international patients.
Sickle cell disease affects millions across Africa. India's haematology centres offer bone marrow transplant and emerging gene therapy options for African patients in 2026.
A comprehensive guide to thalassemia treatment in India for international patients — bone marrow transplant for thalassemia major, curative outcomes, costs, eligibility, chelation therapy, and hospital selection.
A comprehensive guide to blood cancer treatment in India for international patients — leukaemia, lymphoma, and myeloma treatment options, costs, hospitals, and outcomes at JCI-accredited haematology centres.
Complete guide to bone marrow transplant (BMT) in India for international patients — types, costs, eligibility, success rates, and top hospitals in 2026.
Haematology and bone marrow transplant in India — expert BMT centres, 60% cost savings, high success rates. Free case review.
